Clinical Trial Update: UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases [NA]

View source ↗

Summary

An active but not recruiting clinical trial is testing UCAR T-cell therapy targeting CD19/BCMA in patients with systemic lupus erythematosus and systemic sclero…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus
• Systemic Sclerosis

Drugs mentioned

• UCAR T-cell therapy targeting CD19/BCMA

Snippet

Sponsor: The Affiliated Hospital of Xuzhou Medical University | Conditions: Systemic Lupus Erythematosus, Systemic Sclerosis | NA | Status: ACTIVE_NOT_RECRUITING